One of the early promises of PET was that it would be quantitative (1) , as opposed to imaging modalities such as x-ray CT, MRI, or SPECT, in which quantification is more of a challenge than in PET. By quantitative is meant that a raw PET signal can be transferred into absolute activity concentrations of the radiopharmaceutical in all tissues in units of, for example, kBq/cm 3 . In this sense, PET can be classified as quantitative molecular imaging, since it provides the absolute number of radioactive molecules in each desired volume, whether this be a single image voxel or a larger volume of interest. Once the specific activity of the radiopharmaceutical is known,
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PET images can be used for quantitative studies of the biologic processes in which the radioactive molecules are involved.
The transformation of raw PET signals into absolute numbers of radioactive molecules requires several steps, starting with hardware corrections, often referred to as scanner set-up, which deals with, for example, differences in photomultiplier sensitivities and other hardware-related issues. Remaining inhomogeneities are then corrected by a software procedure called normalization. To obtain quantitative images, one has to apply corrections for random coincidences, detector dead time, photon attenuation, and scatter. The first 3 corrections are relatively straightforward, but scatter correction is more complicated and generally uses information on the source distribution obtained from an initial estimate without scatter correction and an attenuation map (1). Finally, for absolute quantification, a further, straightforward step is necessary: cross-calibration of the raw reconstructed image counts with the real activity concentration as derived from measurements in a dose calibrator.
QUANTIFICATION OF TUMOR VOLUME AND 18 F-FDG UPTAKE
Given that quantitative PET images are available, these can be used for pharmacokinetic modeling, oncologic staging, treatment planning, and response monitoring or for other numeric analyses. In general, these studies require volumes of interest, drawn manually, automatically, or semiautomatically around organs, tumors, or other tissues. Volumes of interest provide the sizes and volumes of these regions, as well as the total activity, mean activity concentration, standard deviation, and other measurements. For 18 F-FDG PET in oncology, these analyses have become part of routine clinical practice, next to visual interpretation of the images. Standardized uptake value (SUV), defined as the maximum or mean uptake in a tumor, scaled by the administered activity and by some measure of patient size (body weight, length, or a combination), has become a standard parameter of interest.
However, because of the modest spatial resolution of PET scanners (typically 5-6 mm in full width at half maximum, or down to 2 mm for the most advanced scanner types using special image reconstruction algorithms), SUV and tumor volumes critically depend on the type of scanner, the reconstruction algorithm, and details of the delineation method used, especially for tumor sizes close to or smaller than the spatial resolution of the scanner. Simply stated, the measured activity concentration in a small volume of a PET image will not exactly represent the real value but depends on the activity in neighboring voxels. This is often called partialvolume effect or spillover, which can be separated into spill-out and spill-in depending on whether the volume considered is hotter or colder than surrounding tissues (2).
The partial-volume effect seriously hampers the determination of tumor volumes and corresponding SUVs in PET images. Most commonly, the tumor is delineated using a certain threshold in 18 F-FDG activity concentrations, and the voxels belonging to the tumor are assumed to be those that are above this threshold. However, determining how to define this threshold is not at all trivial. A simple approach, available in most commercial nuclear medicine software packages, is to define the threshold as a fixed percentage of the maximum voxel value within the tumor (e.g., using 50% isocontours).
TUMOR DELINEATION METHODS
Many refinements in threshold definition and other delineation methods have been proposed and investigated.
One can still use a percentage of the maximum voxel value as the threshold, but this percentage can be adapted and can be made dependent on the background activity concentration (3, 4) . Alternatively, a threshold can be defined as a percentage of the mean SUV plus a constant (5) (7) . Also, gradient-based methods exist (8, 9) in which the borders of a tumor are characterized by gradients in activity concentration. Finally, statistical methods dealing with spatial correlations between voxels are being used (10, 11) .
Clearly, generally used and accepted methods for tumor delineation in PET do not yet exist. All methods have separately been described in the literature, have been validated or optimized using phantom experiments, and have sometimes been applied to realistic patient images. However, a comprehensive study in which different methods have been used on the same phantom and patient data, aiming at optimizations and definite conclusions as to which method is best, has been lacking.
A NEW AND VALUABLE CONTRIBUTION TO THE SUBJECT
The report by Tylski et al. in this issue excellently fills this gap (12) . The authors present a systematic approach to the topic, based on both phantom and realistically simulated patient data for a large variety of tumor sizes and tumor-to-backgroundactivity concentration ratios. They clearly identified 2 superior methods based on analyses of their large dataset.
In their experiments, the authors not only used a torso phantom containing lung inserts, a liver insert, and 17 spheres representing the ''tumors'' of variable size and activity concentrations, inserted in the background, the lungs, and the liver inserts, but they also used an elegant method to simulate nonspheric tumors of known size and activity concentration in a real patient PET scan. To this purpose, a real PET scan of a patient with no tumors in the lungs was taken, and 41 realistic tumors of variable sizes and SUVs were inserted in this scan.
All phantom tumors and simulated patient tumors were analyzed by 5 different methods previously described in the literature. Using the terminology of the authors, these methods were T max , T reg , T mean , T bgd , and Fit, where T max uses a threshold based on the maximum voxel value within the tumor, T reg is the regression method using a percentage of the mean SUV plus a constant as the threshold (5), T mean also uses mean SUV but is based on region growth starting with a single voxel within the tumor (6), T bgd uses a combination of the mean SUV and the background activity concentration (4), and Fit is based on convolution of the tumor image with the point-spread function corresponding to the spatial resolution of the scanner (7). The Fit method was initialized using T bgd with a fixed starting parameter; therefore, background activity was intrinsically accounted for in Fit. The SUV estimates were obtained with and without partial-volume correction (13) .
Because all segmentation methods contain 1 or 2 adjustable parameters, the authors optimized these parameters for each method using the phantom data. For the simulated patient scans, the parameters were optimized using additional, simulated phantom data, obtained for the same scanner and acquisition settings. As a measure for the goodness of the method, the authors used the percentage errors in volume estimates and in SUV estimates. Of these parameters, both bias and variability were investigated.
Without addressing all details of the statistical analyses, the overall conclusion of the paper is that T bgd and Fit gave the most accurate tumor volume estimates, with mean errors of 2% 6 11% and 28% 6 21%, respectively. Also with regard to SUV estimates, T bgd and Fit with partial-volume correction performed best, resulting in mean errors of 22% 6 10% and 3% 6 24%, respectively. Remarkably, the commonly used T max yielded considerably larger bias and larger variability in tumor volume and SUV estimates, as shown in Figures 3 and 5 of the paper. The authors also found that some methods were more sensitive than others to the proper settings of parameters. T max , T mean , and T reg had very different biases for the simulated patient data, compared with the phantom data, whereas T bgd and Fit were more constant across these datasets and optimization strategies. This finding led to the conclusion that the latter methods are more robust with regard to parameter settings.
PERSPECTIVE
Tylski et al. have shown for a large variety of ''tumors'' with different sizes, shapes, and tumor-to-background ratios, both in phantoms and simulated in the lungs of a real patient scan, that after optimization of parameters, 2 delineation methods gave satisfactory results whereas others clearly resulted in tumor volumes and SUVs deviating from their true values. These results are a significant step forward, especially in multicenter oncology studies where uniform delineation methods are required (14) . However, implementation of the results does require an effort on site, since the parameter optimizations depend on the type of scanner and image reconstruction algorithm.
Extension to different types of tumors would be interesting, as, for example, liver tumors generally have a higher background activity than lung tumors. Further, it might be worthwhile to also include gradient-based and statistical delineation methods.
Finally, to make intercomparisons of SUVs and tumor volumes more of a routine procedure, it is necessary that advanced delineation algorithms become implemented into commercial
